## **Core Concept**
Fluorouracil is a chemotherapeutic agent used in the treatment of various cancers, including colorectal, breast, and skin cancers. It belongs to the class of antimetabolites, which interfere with DNA synthesis. The primary mechanism of action of fluorouracil involves its interference with thymidylate synthesis.

## **Why the Correct Answer is Right**
The correct answer, , involves the inhibition of thymidylate synthase. Fluorouracil is converted into 5-fluoro-2'-deoxyuridylate (FdUMP), which competitively inhibits thymidylate synthase. Thymidylate synthase is crucial for the conversion of uracil to thymidine, a nucleotide required for DNA synthesis. By inhibiting this enzyme, fluorouracil disrupts DNA synthesis, leading to cell death, particularly in rapidly dividing cancer cells.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while fluorouracil does interact with DNA, its primary mechanism is not through intercalation between DNA base pairs, which is a mechanism more characteristic of anthracyclines like doxorubicin.
- **Option B:** This option is incorrect as fluorouracil's action is not primarily through the inhibition of topoisomerase II, an enzyme targeted by drugs like etoposide.
- **Option C:** Although fluorouracil does affect RNA, saying it acts by being incorporated into RNA is not its primary mechanism of anticancer action. It does get incorporated into RNA, leading to abnormal RNA function, but this is not its main pathway for exerting anticancer effects.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that fluorouracil's efficacy and toxicity can be influenced by the patient's ability to metabolize it, which can vary based on genetic factors. For example, variations in the enzyme dihydropyrimidine dehydrogenase (DPD) can affect how patients metabolize fluorouracil, with DPD deficiency potentially leading to severe toxicity.

## **Correct Answer:** . Inhibition of thymidylate synthase.